Development of omics‐based protocols for the microbiological characterization of multi‐strain formulations marketed as probiotics: the case of VSL#3

The growing commercial interest in multi‐strain formulations marketed as probiotics has not been accompanied by an equal increase in the evaluation of quality levels of these biotechnological products. The multi‐strain product VSL#3 was used as a model to setup a microbiological characterization tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora, Diego, Filardi, Rossella, Arioli, Stefania, Boeren, Sjef, Aalvink, Steven, de Vos, Willem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801179/
https://www.ncbi.nlm.nih.gov/pubmed/31402586
http://dx.doi.org/10.1111/1751-7915.13476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801179/
https://www.ncbi.nlm.nih.gov/pubmed/31402586
http://dx.doi.org/10.1111/1751-7915.13476

Ejemplares similares